Unfolded Protein Response in Lens Epithelial Cells
晶状体上皮细胞中未折叠的蛋白质反应
基本信息
- 批准号:7881521
- 负责人:
- 金额:$ 32.74万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-08-01 至 2013-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressApoptosisBindingBiological AssayCaspaseCataractCell DeathCell SurvivalCellsCellular StressCessation of lifeChemicalsChronicCrystallinsDevelopmentDiabetes MellitusDiseaseDisulfidesEndoplasmic ReticulumEnzymesEpithelialEpithelial CellsEventExhibitsEyeFamilyFree RadicalsGalactosemiasGenesGenetic TranscriptionGlutathioneGrowth FactorHumanLaboratoriesLipoxygenaseMicroarray AnalysisMitochondriaMitoticMolecular ChaperonesPathway interactionsPatientsPharmaceutical PreparationsProductionProtein ConformationProtein Disulfide IsomeraseProteinsRattusReactionReactive Oxygen SpeciesReportingResearchRespiratory ChainRetinal DiseasesRoleSourceStagingStressStudy SubjectTestingTimeTranscription CoactivatorUbiquitinUp-Regulationcell typechromatin immunoprecipitationdesigndiabeticdiabetic cataractdiabetic ratendoplasmic reticulum stresskillingslensnanoparticlenovelnovel therapeutic interventionoxidationpoly(lactide)promoterprophylacticprotein aggregationprotein foldingpublic health relevanceresearch studyresponsestressortauroursodeoxycholic acidtext searchingtrimethyloxamine
项目摘要
DESCRIPTION (provided by applicant): Activation of a stress pathway is a primary cause of many types of cataracts. A search of the literatures has indicated that misfolded protein conformations in the endoplasmic reticulum (ER) induce ER stress, and prolonged ER stress oxidizes and kills numerous cell types. Our laboratory has previously proposed that many cataractogenic stressors also exhibit endoplasmic reticulum (ER) stress and induce well-defined protective and death pathways called the unfolded protein response (UPR). The first stage of the UPR protects cells against stress, and cells eliminate the unfolded modified proteins from the ER by the ubiquitin dependent ER-associated degradation (ERAD). However, prolonged ER stress activates the second stage of the UPR, which leads to activation of the UPR dependent death pathway. The UPR death pathway activates specific proteins including caspases, stimulates Ca++ release and the over production of reactive oxygen species (ROS), and results in LEC death. Lens epithelial cell derived growth factor (LEDGF) is known to be a transcriptional activator and survival factor and rescues various cell types under stress conditions by up-regulating expression of the stress associated genes. A recent study has suggested that prolonged ER stress activates the expression of the ledgf gene. Thus, we propose that the UPR also activates an eclectic survival pathway, which activates the ledgf gene and downstream survival genes to promote cell survival under prolonged ER stress. Chemical chaperones (PBA and TMAO) and TUDCA are reported to suppress ER stress. Recently we showed that these drugs reduced ER stress, delayed LEC death, and alleviated cataract formation. These results opened novel opportunities of research to develop prophylactic drugs for LEC and cataract development. Aim 1 is to test that A) diabetes induces the UPR, which produces ROS, induces LEC death, and promotes cataract formation in rats, B) the UPR induces abnormal LEC proliferation in galactosemic rat LECs, and C) these proliferative LECs are preferentially attacked by ER stress. We believe that these above events are involved in cataract development. Aim 2 is to test whether LEDGF is a prosurvival downstream activator in the UPR and if the UPR pathway regulates the transcription of the ledgf gene in galactosemic LECs. Stimulation of the LEDGF protective pathway could be another way of alleviating cataract in chronic diabetes. Aim 3 is to test whether chemical chaperones and TUDCA can be used as prophylactic agents to suppress the death of LECs in galactosemic and diabetic cataract. The drugs will be trapped in poly-lactide-co-glycolides (PLGA) nanoparticles and directly inject into the vitreal space. The PLGA can deliver larger amounts of drugs and slowly release these drugs over a long time. PUBLIC HEALTH RELEVANCE: Activation of stress pathway is a primary cause of many types of diseases including cataracts. One form of stress, so called endoplasmic reticulum (ER) stress, is caused by misfolded protein conformation. The ER stress produces reactive oxygen species (ROS) to oxidize free glutathione and proteins and induces cell death in the lens. We will study the roles of the UPR in lens epithelial cell death and cataract fromation in diabetic and galactosemic rats. Furthermore, lens epithelial derived growth factor (LEDGF) is elevated in cells under ER stress, we will study the basic notion of up-regulation of LEDGF in the UPR pathway, which may open an alternative survival pathway. Finally, chemical chaperones and TUDCA are known to reduce ER stress dependent cell death. We will study whether these chaperones and TUDCA can be used as prophylactic drugs to suppress ER stress, ROS production, LEC death, and cataract development. Modulating ER stress by these chaperones and TUDCA may offer a novel therapeutic approach to the treatment of human patients with cataract.
描述(由申请人提供):应激途径的激活是许多类型白内障的主要原因。文献检索表明,内质网(ER)中错误折叠的蛋白质构象诱导ER应激,并且长时间的ER应激氧化并杀死许多细胞类型。我们的实验室以前提出,许多白内障的应激源也表现出内质网(ER)应激,并诱导明确的保护和死亡途径,称为未折叠蛋白反应(UPR)。UPR的第一阶段保护细胞免受应激,并且细胞通过泛素依赖性ER相关降解(ERAD)从ER消除未折叠的修饰蛋白。然而,延长的ER应激激活UPR的第二阶段,这导致UPR依赖性死亡途径的激活。UPR死亡途径激活特定的蛋白质,包括半胱天冬酶,刺激Ca++释放和活性氧(ROS)的过度产生,并导致LEC死亡。已知透镜上皮细胞衍生生长因子(LEDGF)是转录激活因子和存活因子,并通过上调应激相关基因的表达来拯救应激条件下的各种细胞类型。最近的一项研究表明,长期的ER应激激活了ledgf基因的表达。因此,我们认为UPR还激活了一个折衷的生存途径,它激活了ledgf基因和下游生存基因,以促进细胞在长期ER应激下的生存。据报道,化学伴侣(PBA和TMAO)和TUDCA抑制ER应激。最近,我们发现这些药物可以降低ER应激,延缓LEC死亡,减轻白内障的形成。这些结果为开发LEC和白内障发展的预防药物开辟了新的研究机会。目的1是测试A)糖尿病诱导UPR,其产生ROS,诱导LEC死亡,并促进大鼠中的白内障形成,B)UPR诱导半乳糖血症大鼠LEC中的异常LEC增殖,以及C)这些增殖的LEC优先受到ER应激的攻击。我们认为上述事件与白内障的发生有关。目的2是测试LEDGF是否是UPR中的促生存下游激活剂,以及UPR途径是否调节半乳糖血症LEC中ledgf基因的转录。刺激LEDGF保护通路可能是缓解慢性糖尿病白内障的另一种方法。目的3:检测化学分子伴侣和TUDCA是否可以作为预防剂来抑制半乳糖血症和糖尿病性白内障中晶状体上皮细胞的死亡。药物将被捕获在聚丙交酯-共-乙交酯(PLGA)纳米颗粒中,并直接注入玻璃体空间。PLGA可以提供更大量的药物,并在很长一段时间内缓慢释放这些药物。公共卫生相关性:应激途径的激活是包括白内障在内的多种疾病的主要原因。一种形式的应激,所谓的内质网(ER)应激,是由错误折叠的蛋白质构象引起的。ER应激产生活性氧(ROS)以氧化游离谷胱甘肽和蛋白质并诱导透镜中的细胞死亡。我们将研究UPR在糖尿病和半乳糖血症大鼠透镜上皮细胞死亡和白内障形成中的作用。此外,透镜上皮衍生生长因子(LEDGF)在ER应激下细胞中升高,我们将研究LEDGF在UPR通路中上调的基本概念,这可能打开另一种存活途径。最后,已知化学分子伴侣和TUDCA减少ER应激依赖性细胞死亡。我们将研究这些分子伴侣和TUDCA是否可以作为预防性药物来抑制ER应激,ROS产生,LEC死亡和白内障的发展。通过这些分子伴侣和TUDCA调节ER应激可能为治疗人类白内障患者提供一种新的治疗方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TOSHIMICHI SHINOHARA其他文献
TOSHIMICHI SHINOHARA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TOSHIMICHI SHINOHARA', 18)}}的其他基金
Unfolded Protein Response in Lens Epithelial Cells
晶状体上皮细胞中未折叠的蛋白质反应
- 批准号:
7525967 - 财政年份:2008
- 资助金额:
$ 32.74万 - 项目类别:
Unfolded Protein Response in Lens Epithelial Cells
晶状体上皮细胞中未折叠的蛋白质反应
- 批准号:
8091250 - 财政年份:2008
- 资助金额:
$ 32.74万 - 项目类别:
Unfolded Protein Response in Lens Epithelial Cells
晶状体上皮细胞中未折叠的蛋白质反应
- 批准号:
8278639 - 财政年份:2008
- 资助金额:
$ 32.74万 - 项目类别:
Unfolded Protein Response in Lens Epithelial Cells
晶状体上皮细胞中未折叠的蛋白质反应
- 批准号:
7667246 - 财政年份:2008
- 资助金额:
$ 32.74万 - 项目类别:
AGE RELATED CATARACT--ANTIBODY MEDIATED AUTOIMMUNE DISEA
年龄相关性白内障--抗体介导的自身免疫性疾病
- 批准号:
2608666 - 财政年份:1995
- 资助金额:
$ 32.74万 - 项目类别:
AGE RELATED CATARACT--ANTIBODY MEDIATED AUTOIMMUNE DISEA
年龄相关性白内障--抗体介导的自身免疫性疾病
- 批准号:
2165157 - 财政年份:1995
- 资助金额:
$ 32.74万 - 项目类别:
AGE RELATED CATARACT--ANTIBODY MEDIATED AUTOIMMUNE DISEA
年龄相关性白内障--抗体介导的自身免疫性疾病
- 批准号:
2019975 - 财政年份:1995
- 资助金额:
$ 32.74万 - 项目类别:
相似国自然基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
- 批准号:LBY21H010001
- 批准年份:2020
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
- 批准号:81703335
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
- 批准号:81670594
- 批准年份:2016
- 资助金额:58.0 万元
- 项目类别:面上项目
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
- 批准号:81470791
- 批准年份:2014
- 资助金额:73.0 万元
- 项目类别:面上项目
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
- 批准号:81301123
- 批准年份:2013
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
- 批准号:81101529
- 批准年份:2011
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
- 批准号:39500043
- 批准年份:1995
- 资助金额:9.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Apoptosis regulation by RNA binding proteins
RNA 结合蛋白的细胞凋亡调节
- 批准号:
DDG-2015-00002 - 财政年份:2016
- 资助金额:
$ 32.74万 - 项目类别:
Discovery Development Grant
Apoptosis regulation by RNA binding proteins
RNA 结合蛋白的细胞凋亡调节
- 批准号:
DDG-2015-00002 - 财政年份:2015
- 资助金额:
$ 32.74万 - 项目类别:
Discovery Development Grant
Mechanisms Of RNA-Binding Protein-Mediated Apoptosis In Oral Mucositis
RNA结合蛋白介导的口腔粘膜炎细胞凋亡机制
- 批准号:
9237260 - 财政年份:2013
- 资助金额:
$ 32.74万 - 项目类别:
Mechanisms Of RNA-Binding Protein-Mediated Apoptosis In Oral Mucositis
RNA结合蛋白介导的口腔粘膜炎细胞凋亡机制
- 批准号:
8657030 - 财政年份:2013
- 资助金额:
$ 32.74万 - 项目类别:
Apoptosis regulation by RNA binding proteins
RNA 结合蛋白的细胞凋亡调节
- 批准号:
261206-2009 - 财政年份:2013
- 资助金额:
$ 32.74万 - 项目类别:
Discovery Grants Program - Individual
Mechanisms Of RNA-Binding Protein-Mediated Apoptosis In Oral Mucositis
RNA结合蛋白介导的口腔粘膜炎细胞凋亡机制
- 批准号:
8993725 - 财政年份:2013
- 资助金额:
$ 32.74万 - 项目类别:
Mechanisms Of RNA-Binding Protein-Mediated Apoptosis In Oral Mucositis
RNA结合蛋白介导的口腔粘膜炎细胞凋亡机制
- 批准号:
8503886 - 财政年份:2013
- 资助金额:
$ 32.74万 - 项目类别:
Apoptosis regulation by RNA binding proteins
RNA 结合蛋白的细胞凋亡调节
- 批准号:
261206-2009 - 财政年份:2012
- 资助金额:
$ 32.74万 - 项目类别:
Discovery Grants Program - Individual
The binding and apoptosis inhibitory action to germ cells of relaxin-like peptide expressed in the boar testis
公猪睾丸表达的松弛素样肽与生殖细胞的结合及凋亡抑制作用
- 批准号:
24580408 - 财政年份:2012
- 资助金额:
$ 32.74万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of the Insulin-like Growth Factor 2 mRNA Binding Protein (IGF2BP1) as an important regulator of cIAP1 translation and apoptosis in Rhabdomyosarcomas
鉴定胰岛素样生长因子 2 mRNA 结合蛋白 (IGF2BP1) 作为横纹肌肉瘤中 cIAP1 翻译和细胞凋亡的重要调节因子
- 批准号:
269093 - 财政年份:2012
- 资助金额:
$ 32.74万 - 项目类别:














{{item.name}}会员




